1. Home
  2. IMXI vs CLLS Comparison

IMXI vs CLLS Comparison

Compare IMXI & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Money Express Inc.

IMXI

International Money Express Inc.

HOLD

Current Price

$13.03

Market Cap

469.3M

Sector

Technology

ML Signal

HOLD

Logo Cellectis S.A.

CLLS

Cellectis S.A.

N/A

Current Price

$2.84

Market Cap

394.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IMXI
CLLS
Founded
1994
1999
Country
United States
France
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
469.3M
394.4M
IPO Year
2016
2014

Fundamental Metrics

Financial Performance
Metric
IMXI
CLLS
Price
$13.03
$2.84
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$15.00
$8.33
AVG Volume (30 Days)
342.7K
17.7K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$319,601,000.00
N/A
Revenue This Year
$0.83
N/A
Revenue Next Year
$1.49
$0.98
P/E Ratio
$666.00
N/A
Revenue Growth
16.68
N/A
52 Week Low
$8.58
$2.44
52 Week High
$15.95
$5.48

Technical Indicators

Market Signals
Indicator
IMXI
CLLS
Relative Strength Index (RSI) 33.86 45.92
Support Level N/A $2.70
Resistance Level $15.38 $3.40
Average True Range (ATR) 0.37 0.13
MACD -0.07 0.00
Stochastic Oscillator 10.47 32.91

Price Performance

Historical Comparison
IMXI
CLLS

About IMXI International Money Express Inc.

International Money Express Inc is an omnichannel money remittance services company focused on the United States of America to Latin America and the Caribbean corridor, which includes Mexico, Central and South America and the Caribbean. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: